Shots:

• The US FDA has authorized EUA of mRNA-1273 vaccine against COVID-19 in individuals ≥18yrs. The delivery to the US govt. will begin imminently while Moderna will continue to gather additional data and plans to file BLA for full licensure in 2021
• Allocation and distribution will be prioritized according to populations identified by the CDC’s ACIP. The Company expects to have b/w 100-125M doses available globally in the Q1’21- with 85-100M of those available in the US
• The US govt. ordered total 200M doses to date & retains an option to purchase up to an additional 300M doses- ~20M doses will be delivered by the end of Dec 2020

­ Ref: Moderna | Image: Moderna